1Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver [J]. Seminars in liver Disease,2002,22(2) :145 -55.
4Benichou C. Criteria of drug - induced liver disorder. Reports of international consensus meeting[J]. J Hepatol, 1990,11:272 - 6.
5PhRMA/FDA/AASLD Drug-induced Hepatotoxicity White Paper.Postmarketing Consideration. February, 2001.
6Zimmeman HJ, Ishak KG. Hepatic injury due to drugs and toxins.In: MacSween RMN,Burt AD,Portmann BC, eds. Patholgy of the liver. 4th edition. London :Churchill Livingstone ,2002 :621 -710.
7Danan G, Benichou C. Causality assessment of adverse reaction to drug- Ⅰ. A novel method based on the conclusions of international oonsensus meeting: application to drug - induced liver injuries [J]. J Clin Epidemiol, 1993,46:1323 - 30.
8Aithal GP, Rawlins MD, Day GP. Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatoxic adverse drug reactions[J]. J Hepatol. 2000,33:949 -52.
9Lucena I, Camargo R, Andrade J,et al. Comparison of two clinical scales for causality assessment in hepatotoxity [J]. Hepatology,2001,33:123 -30.
10Ostapowicz G,Fontana RJ,Larson AM, et al. Etiology and outcome of acute liver failure in the USA: preliminary results of prospective multi-center study[J]. Hepatology. 1999,30:221A.
